spacer

CDC HomeHIV/AIDS > Topics > Testing > Guidelines > HIV Testing Implementation Guidance for Correctional Settings HIV Testing

space HIV Testing Implementation Guidance for Correctional Settings
space
arrow Authors
space
arrow Introduction
space
arrow Section I
space
arrow Section II
space
arrow Section III
space
arrow Section IV
space
arrow Section V
space
arrow Section VI
space
arrow Section VII
space
arrow Section VIII
space
arrow Section IX
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
Section VIII: References
spacer
spacer
  1. Sabol WJ, Couture H. Prison Inmates at Midyear 2007. Washington, DC: Office of Justice Programs, U.S. Department of Justice; 2008.
  2. Maruschak LM. HIV in Prisons, 2006. Washington, DC: Office of Justice Programs, U.S. Department of Justice; 2008.
  3. Maruschak LM. Medical Problems of Jail Inmates. Washington, DC: Office of Justice Programs, U.S. Department of Justice; 2006.
  4. Maruschak LM. HIV in Prisons and Jails, 2002. Washington, DC: Office of Justice Programs, U.S. Department of Justice; 2004.
  5. Marks G, Crepaz N, Senterfitt JW, Janssen R. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for prevention programs. JAIDS. 2005;39(4):446–453.
  6. Kacanek D, Eldridge G, Nealey-Moore J, et al. HIV Testing Among Young Men with a History of Incarceration. AJPH. 2007;97(7):1241–1248.
  7. MacGowan RJ, Eldridge GD, Sosman JM, et al. HIV counseling and testing of young men in prison. J Correctional Health-care. 2006;12(3):203–213.
  8. Maruschak LM. HIV in Prisons, 2004. Washington, DC: Office of Justice Programs, U.S. Department of Justice; 2006.
  9. Lifson AR, Rybicki SL. Routine opt-out HIV testing. Lancet. 2007;369(9561):539–540.
  10. Hoxie NJ, Vergeront JM, Frisby HR, Pfister JR, Golubjatnikov R, Davis J. HIV Seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am J Public Health. 1990;80:1129–1131.
  11. Desai AA, Latta TE, Spaulding A, Rich JD, Flanigan TP. The Importance of Routine HIV Testing in the Incarcerated Population: The Rhode Island Experience. AIDS Educ Prev. 2002;14(Supplement B):45–52.
  12. Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for Human Immunodeficiency Virus (HIV) in a prison population with a high prevalence of HIV. 1994; 139:9:918–926.
  13. Harawa N, Butler Q, Bingham T. “Who to screen? Unrecognized HIV infection by arrest reason among jail inmates in Los Angeles.” Presentation. Natl HIV Prev Conf 2005 Jun 14: abstract no. T2–D0202. Atlanta, GA.
  14. MacGowan R, Margolis A, Richardson-Moore A, Wang T, Lalota M, French PT, Stodola J, McKeever J, Carrel J, Mullins J, Llanas M, Griffiths SD, for the Rapid Testing in Corrections (RTC) Team. Voluntary rapid human immunodeficiency virus (HIV) testing in jails [published online ahead of print August 23, 2007]. SexTransm Dis. 2007. doi:10.1097/OLQ.0b013e318148b6b1.
  15. Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, Hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS. 2005; Suppl 3:S41–6.
  16. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17.
  17. Wasserheit JN. Epidemiologic synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;9:61–77.
  18. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized controlled trial. Lancet. 1995;346:630–636.
  19. Wasserheit JN, Aral SO. The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J Infect Dis. 1996;174:S201–S213.
  20. Zierler S, Krieger N, Tang Y, et al. Economic deprivation and AIDS incidence in Massachusetts. Am J Public Health. 2000;90(7):1064–73.
  21. Simon PA, Hu DJ, Diaz T, Kerndt PR. Income and AIDS rates in Los Angeles County. AIDS. 1995;9(3):281–284.
  22. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, by race/ethnicity, 2000–2004. HIV/AIDS Surveillance Supplemental Report. 2006;12(1):1–36.
  23. Clements-Nolle K, Marx R, Guzman R, Katz M. HIV prevalence, risk behaviors, health-care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health. 2001; 91(6):915–921.
  24. Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: A systematic review. AIDS Beh. 2007;DOI 10.1007/s10461-007-9299-3.
  25. Simon PA, Reback CJ, Bemis CC. HIV prevalence and incidence among male-to-female transsexuals receiving HIV prevention services in Los Angeles County. AIDS. 2000;14(18):2953–2955.
  26. McClelland GM, Teplin LA, Abram KM, Jacobs N. HIV and AIDS risk behaviors among female jail detainees: implications for public health policy. Am J Public Health. 2002;92:818–25.
  27. Beckwith CG, Atunah-Jay S, Cohen J, et al. Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care & STD. 2007;21(1):41–47.
  28. Centers for Disease Control and Prevention and Prevention of Opportunistic Infections Working Group. Guidelines for the Prevention of Opportunistic Infections Among HIV-Infected Persons 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. 2002; accessed October, 2007.
  29. Spaulding AC, Arriola K, Ramos K, et al. Enhancing Linkages to HIV Primary Care in Jail Settings: Report on a Consultant’s Meeting. Journal Correctional Health Care. 2007;13(2):93–128.
  30. Centers for Disease Control. Technical guidance on HIV counseling. MMWR. 1993;42(No.RR-2):11–17.
  31. Centers for Disease Control and Prevention. Revised Recommendations for HIV testing in adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(RR-14):1–13.
  32. National Institute of Health. AIDS info.
  33. HIV/AIDS Practice Guidelines at HIV Medicine Association (HIVMA).Link to non-CDC web site
  34. University of California, San Francisco. National HIV/AIDS Clinicians’ Consultation Center.Link to non-CDC web site
  35. Centers for Disease Control and Prevention. Recommended Adult immunization Schedule–United States, October 2007–September 2008. MMWR. 2007;56(41):Q1–Q4.
  36. Stone VE, Mansourati FF, Poses RM, Mayer KH. Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy. J Gen Intern Med. 2001;16:360–68.
  37. Landon BE, Wilson IB, Wenger NS, et al. Specialty training and specialization among HIV physicians in the United States. J Gen Intern Med. 2002;17(1):12–22.
  38. Kitahata MM, Koepsell TD, Deyo A, Maxwell CL, Dodge WT, Wagner EH. Experience with the Acquired Immunodeficiency Syndrome as a factor in inmates’ survival. New Engl J Med. 1996;334:701–706.
  39. Laine C, Markson LE, McKee LJ, Hauck WW, Fanning TR, Turner BJ. The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS. 1998;12(417–424).
  40. Kim JY, Rich J, Zeiler S, et al. Successful community follow-up and reduced recidivism of HIV-positive women prisoners. Journal of Correctional Health Care. 1997;4:1–9.
  41. Springer S, Pesanti E, Hodges T, Macura T, Doros G, Altice F. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38:1754–60.
  42. Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120(1):84–88.
  43. Vigilante KC, Flynn MM, Affleck PC, et al. Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning. Journal of Women’s Health. 1999(8):409-415.
  44. Flanigan TP, Kim JY, Zierler S, Rich JD, Vigilante K, Bury-Maynard D. A prison release program for HIV-positive women: linking them to health services and community follow-up. Am J Public Health. 1996;86:886–887.
  45. Skolnick AA. Correctional and community health care collaborations. Journal of the American Medical Association. 1998;279:98–99.
  46. Health Resources and Services Administration. Ryan White HIV/AIDS Treatment Modernization Act of 2006; accessed April, 2007.
  47. Conklin TJ, Lincoln T, Flanigan TP. A public health model to connect correctional health-care with communities. Am J Public Health. 1998;88:1249–1250.
  48. Federal Bureau of Prisons. Management of HIV. Federal Bureau of Prisons Clinical Practice Guidelines.PDF icon June, 2006; accessed December, 2007.

Go to Section IX

spacer
Last Modified: January 30, 2009
Last Reviewed: January 30, 2009
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
horizontal dividing line
Contact Us
Please click here to view contact information.
divider
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 8A-8P (EST) M-F. Closed weekends and major federal holidays - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services